• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Millennium Pharmaceuticals

Millennium Pharmaceuticals

  1. All
  2. 3rd Party
  3. Investing
  1. Amgen's Myeloma Treatment Study Fails to Meet Primary Endpoint

    Amgen's Myeloma Treatment Study Fails to Meet Primary Endpoint

  2. Decibel Therapeutics Expands Leadership Team

    Decibel Therapeutics Expands Leadership Team

  3. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.